Skip to main content
SpringerLink
Log in

Overlap Syndromes of Primary Sclerosing Cholangitis

  • Chapter
  • First Online:
Primary Sclerosing Cholangitis

  • 722 Accesses

Abstract

Primary sclerosing cholangitis can have features of autoimmune hepatitis or primary biliary cholangitis. Overlapping features with primary biliary cholangitis occur in only 0.7 % of patients, but concurrent findings of autoimmune hepatitis occur in 4–17 %. Overlapping features can be present at onset or develop in sequence. Laboratory indices of marked liver inflammation, serological markers of immune reactivity, and histological findings of interface hepatitis with dense lymphoplasmacytic infiltration suggest an overlap syndrome with autoimmune hepatitis. Antimitochondrial antibodies and histological findings of destructive cholangitis suggest an overlap syndrome with primary biliary cholangitis. Overlap syndromes of primary sclerosing cholangitis involving the small bile ducts may have a better long-term prognosis than disease involving the large bile ducts. Treatment is directed at the predominant disease component and tailored to the individual response. Prednisolone and azathioprine have been the principal drugs used in treating the overlap syndrome with autoimmune hepatitis, and ursodeoxycholic acid has been the main drug used in treating the overlap syndrome with primary biliary cholangitis. The inflammatory indices commonly improve and may normalize in patients with features of autoimmune hepatitis, whereas the cholestatic indices usually remain abnormal. Histological progression can occur despite laboratory improvement, and survival has ranged from 56 to 100 %. Liver transplantation has been required in at least 19 %, and malignancies develop in 0–12 %. Patients with features of primary biliary cholangitis can improve liver tests to normal or near normal and remain stable for up to 17 years. Overlap syndromes must be considered in all patients with atypical manifestations and disease progression.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology. 1981;1:632–40.

    Article  CAS  PubMed  Google Scholar 

  2. Ludwig J, Czaja AJ, Dickson ER, LaRusso NF, Wiesner RH. Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology. Liver. 1984;4:105–16.

    Article  CAS  PubMed  Google Scholar 

  3. Barbatis C, Grases P, Shepherd HA, Chapman RW, Trowell J, Jewell DP, et al. Histological features of sclerosing cholangitis in patients with chronic ulcerative colitis. J Clin Pathol. 1985;38:778–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Portmann B, Zen Y. Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation. Histopathology. 2012;60:236–48.

    Article  PubMed  Google Scholar 

  5. Azizi L, Raynal M, Cazejust J, Ruiz A, Menu Y, Arrive L. MR imaging of sclerosing cholangitis. Clin Res Hepatol Gastroenterol. 2012;36:130–8.

    Article  CAS  PubMed  Google Scholar 

  6. Arrive L, Ruiz A, El Mouhadi S, Azizi L, Monnier-Cholley L, Menu Y. MRI of cholangitis: traps and tips. Diagn Interv Imaging. 2013;94:757–70.

    Article  CAS  PubMed  Google Scholar 

  7. Ruiz A, Lemoinne S, Carrat F, Corpechot C, Chazouilleres O, Arrive L. Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology. 2014;59:242–50.

    Article  PubMed  Google Scholar 

  8. Angulo P, Pearce DH, Johnson CD, Henry JJ, LaRusso NF, Petersen BT, et al. Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis. J Hepatol. 2000;33:520–7.

    Article  CAS  PubMed  Google Scholar 

  9. Berstad AE, Aabakken L, Smith HJ, Aasen S, Boberg KM, Schrumpf E. Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2006;4:514–20.

    Article  PubMed  Google Scholar 

  10. Talwalkar JA, Angulo P, Johnson CD, Petersen BT, Lindor KD. Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis. Hepatology. 2004;40:39–45.

    Article  PubMed  Google Scholar 

  11. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med. 1996;125:588–98.

    Article  CAS  PubMed  Google Scholar 

  12. Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology. 1998;28:360–5.

    Article  CAS  PubMed  Google Scholar 

  13. Czaja AJ. Variant forms of autoimmune hepatitis. Curr Gastroenterol Rep. 1999;1:63–70.

    Article  CAS  PubMed  Google Scholar 

  14. Ben-Ari Z, Czaja AJ. Autoimmune hepatitis and its variant syndromes. Gut. 2001;49:589–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Czaja AJ. The overlap syndromes of autoimmune hepatitis. Dig Dis Sci. 2013;58:326–43.

    CAS  PubMed  Google Scholar 

  16. Czaja AJ. Diagnosis and management of the overlap syndromes of autoimmune hepatitis. Can J Gastroenterol. 2013;27:417–23.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Czaja AJ. Cholestatic phenotypes of autoimmune hepatitis. Clin Gastroenterol Hepatol. 2014;12:1430–8.

    Article  CAS  PubMed  Google Scholar 

  18. Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology. 1996;23:1369–76.

    Article  CAS  PubMed  Google Scholar 

  19. Gohlke F, Lohse AW, Dienes HP, Lohr H, Marker-Hermann E, Gerken G, et al. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol. 1996;24:699–705.

    Article  CAS  PubMed  Google Scholar 

  20. McNair AN, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am J Gastroenterol. 1998;93:777–84.

    Article  CAS  PubMed  Google Scholar 

  21. Koskinas J, Raptis I, Manika Z, Hadziyannis S. Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis. Eur J Gastroenterol Hepatol. 1999;11:1421–4.

    Article  CAS  PubMed  Google Scholar 

  22. Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol. 2000;33:537–42.

    Article  CAS  PubMed  Google Scholar 

  23. van Buuren HR, van Hoogstraten HJE, Terkivatan T, Schalm SW, Vleggaar FP. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol. 2000;33:543–8.

    Article  PubMed  Google Scholar 

  24. Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology. 2001;33:544–53.

    Article  CAS  PubMed  Google Scholar 

  25. Takiguchi J, Ohira H, Rai T, Shishido S, Tojo J, Sato Y, et al. Autoimmune hepatitis overlapping with primary sclerosing cholangitis. Intern Med. 2002;41:696–700.

    Article  PubMed  Google Scholar 

  26. Floreani A, Rizzotto ER, Ferrara F, Carderi I, Caroli D, Blasone L, et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol. 2005;100:1516–22.

    Article  PubMed  Google Scholar 

  27. Saich R, Chapman R. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol. 2008;14:331–7.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Luth S, Kanzler S, Frenzel C, Kasper HU, Dienes HP, Schramm C, et al. Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. J Clin Gastroenterol. 2009;43:75–80.

    Article  PubMed  Google Scholar 

  29. Olsson R, Glaumann H, Almer S, Broome U, Lebrun B, Bergquist A, et al. High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis. Eur J Intern Med. 2009;20:190–6.

    Article  PubMed  Google Scholar 

  30. Hunter M, Loughrey MB, Gray M, Ellis P, McDougall N, Callender M. Evaluating distinctive features for early diagnosis of primary sclerosing cholangitis overlap syndrome in adults with autoimmune hepatitis. Ulster Med J. 2011;80:15–8.

    PubMed  PubMed Central  Google Scholar 

  31. Rojas CP, Bodicharla R, Campuzano-Zuluaga G, Hernandez L, Rodriguez MM. Autoimmune hepatitis and primary sclerosing cholangitis in children and adolescents. Fetal Pediatr Pathol. 2014;33:202–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Rubel LR, Seeff LB, Patel V. Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome. Arch Pathol Lab Med. 1984;108:360–1.

    CAS  PubMed  Google Scholar 

  33. Burak KW, Urbanski SJ, Swain MG. A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases. Dig Dis Sci. 2001;46:2043–7.

    Article  CAS  PubMed  Google Scholar 

  34. Kingham JG, Abbasi A. Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective. Eur J Gastroenterol Hepatol. 2005;17:1077–80.

    Article  PubMed  Google Scholar 

  35. Jeevagan A. Overlap of primary biliary cirrhosis and primary sclerosing cholangitis: a rare coincidence or a new syndrome. Int J Gen Med. 2010;3:143–6.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Oliveira EM, Oliveira PM, Becker V, Dellavance A, Andrade LE, Lanzoni V, et al. Overlapping of primary biliary cirrhosis and small duct primary sclerosing cholangitis: first case report. J Clin Med Res. 2012;4:429–33.

    PubMed  PubMed Central  Google Scholar 

  37. Floreani A, Motta R, Cazzagon N, Franceschet I, Roncalli M, Del Ross T, et al. The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. Dig Liver Dis. 2015;47:432–5.

    Article  PubMed  Google Scholar 

  38. Lacerda MA, Ludwig J, Dickson ER, Jorgensen RA, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol. 1995;90:247–9.

    CAS  PubMed  Google Scholar 

  39. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology. 2000;31:1231–8.

    Article  CAS  PubMed  Google Scholar 

  40. Kim WR, Ludwig J, Lindor KD. Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol. 2000;95:1130–8.

    Article  CAS  PubMed  Google Scholar 

  41. Angulo P, Maor-Kendler Y, Lindor KD. Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology. 2002;35:1494–500.

    Article  PubMed  Google Scholar 

  42. Bjornsson E, Olsson R, Bergquist A, Lindgren S, Braden B, Chapman RW, et al. The natural history of small-duct primary sclerosing cholangitis. Gastroenterology. 2008;134:975–80.

    Article  PubMed  Google Scholar 

  43. Goodman ZD, McNally PR, Davis DR, Ishak KG. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci. 1995;40:1232–42.

    Article  CAS  PubMed  Google Scholar 

  44. Invernizzi P, Crosignani A, Battezzati PM, Covini G, De Valle G, Larghi A, et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology. 1997;25:1090–5.

    Article  CAS  PubMed  Google Scholar 

  45. Nakanuma Y, Harada K, Kaji K, Terasaki S, Tsuneyama K, Moteki S, et al. Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies. Liver. 1997;17:281–7.

    Article  CAS  PubMed  Google Scholar 

  46. Muratori P, Muratori L, Gershwin ME, Czaja AJ, Pappas G, MacCariello S, et al. 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol. 2004;135:154–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol. 2011;54:374–85.

    Article  PubMed  Google Scholar 

  48. Al-Chalabi T, Portmann BC, Bernal W, McFarlane IG, Heneghan MA. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival. Aliment Pharmacol Ther. 2008;28:209–20.

    Article  CAS  PubMed  Google Scholar 

  49. Perdigoto R, Carpenter HA, Czaja AJ. Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. J Hepatol. 1992;14:325–31.

    Article  CAS  PubMed  Google Scholar 

  50. Abdo AA, Bain VG, Kichian K, Lee SS. Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome. Hepatology. 2002;36:1393–9.

    Article  PubMed  Google Scholar 

  51. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology. 1980;79:200–6.

    CAS  PubMed  Google Scholar 

  52. Zauli D, Schrumpf E, Crespi C, Cassani F, Fausa O, Aadland E. An autoantibody profile in primary sclerosing cholangitis. J Hepatol. 1987;5:14–8.

    Article  CAS  PubMed  Google Scholar 

  53. Lo SK, Fleming KA, Chapman RW. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut. 1992;33:1370–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut. 1992;33:657–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AE, et al. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol. 2000;32:182–7.

    Article  CAS  PubMed  Google Scholar 

  56. Terjung B, Worman HJ. Anti-neutrophil antibodies in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol. 2001;15:629–42.

    Article  CAS  PubMed  Google Scholar 

  57. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980;21:870–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol. 1987;22:655–64.

    Article  CAS  PubMed  Google Scholar 

  59. Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology. 1995;108:1159–66.

    Article  CAS  PubMed  Google Scholar 

  60. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.

    Article  CAS  PubMed  Google Scholar 

  61. Czaja AJ. Autoimmune hepatitis. Part B: diagnosis. Expert Rev Gastroenterol Hepatol. 2007;1:129–43.

    Article  CAS  PubMed  Google Scholar 

  62. Czaja AJ. Diagnosis and management of autoimmune hepatitis. Clin Liver Dis. 2015;19:57–79.

    Article  PubMed  Google Scholar 

  63. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193–213.

    Article  CAS  PubMed  Google Scholar 

  64. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998–1005.

    Article  CAS  PubMed  Google Scholar 

  65. Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology. 2008;48:1540–8.

    Article  PubMed  Google Scholar 

  66. Papamichalis PA, Zachou K, Koukoulis GK, Veloni A, Karacosta EG, Kypri L, et al. The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis. 2007;4:3.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Gatselis NK, Zachou K, Papamichalis P, Koukoulis GK, Gabeta S, Dalekos GN, et al. Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? Dig Liver Dis. 2010;42:807–12.

    Article  PubMed  Google Scholar 

  68. Yamamoto K, Terada R, Okamoto R, Hiasa Y, Abe M, Onji M, et al. A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease. J Gastroenterol. 2003;38:52–9.

    Article  CAS  PubMed  Google Scholar 

  69. Gur H, Shen G, Sutjita M, Terrberry J, Alosachie I, Barka N, et al. Autoantibody profile of primary sclerosing cholangitis. Pathobiology. 1995;63:76–82.

    Article  CAS  PubMed  Google Scholar 

  70. Pratico AD, Salafia S, Barone P, La Rosa M, Leonardi S. Type II autoimmune hepatitis and small duct sclerosing cholangitis in a seven years Old child: an overlap syndrome? Hepat Mon. 2013;13, e14452.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Kenny RP, Czaja AJ, Ludwig J, Dickson ER. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci. 1986;31:705–11.

    Article  CAS  PubMed  Google Scholar 

  72. Muratori P, Granito A, Quarneti C, Ferri S, Menichella R, Cassani F, et al. Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol. 2009;50:1210–8.

    Article  PubMed  Google Scholar 

  73. Zachou K, Gatselis N, Papadamou G, Rigopoulou EI, Dalekos GN. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients. J Hepatol. 2011;55:636–46.

    Article  CAS  PubMed  Google Scholar 

  74. Carpenter HA, Czaja AJ. The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants. Clin Liver Dis. 2002;6:685–705.

    Article  PubMed  Google Scholar 

  75. Burak KW, Angulo P, Lindor KD. Is there a role for liver biopsy in primary sclerosing cholangitis? Am J Gastroenterol. 2003;98:1155–8.

    Article  PubMed  Google Scholar 

  76. Lindor KD, Kowdley KV, Harrison ME. ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015;110:646–59.

    Article  CAS  PubMed  Google Scholar 

  77. Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology. 1993;105:1824–32.

    Article  CAS  PubMed  Google Scholar 

  78. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. AASLD Practice Guidelines. Primary biliary cirrhosis. Hepatology. 2009;50:291–308.

    Article  PubMed  Google Scholar 

  79. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–78.

    Article  CAS  PubMed  Google Scholar 

  80. Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children: what is different from adult AIH? Semin Liver Dis. 2009;29:297–306.

    Article  PubMed  Google Scholar 

  81. Mieli-Vergani G, Vergani D. Autoimmune liver diseases in children: what is different from adulthood? Best Pract Res Clin Gastroenterol. 2011;25:783–95.

    Article  PubMed  Google Scholar 

  82. Mieli-Vergani G, Vergani D. Unique features of primary sclerosing cholangitis in children. Curr Opin Gastroenterol. 2010;26:265–8.

    Article  PubMed  Google Scholar 

  83. Lewin M, Vilgrain V, Ozenne V, Lemoine M, Wendum D, Paradis V, et al. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study. Hepatology. 2009;50:528–37.

    Article  PubMed  Google Scholar 

  84. Abdalian R, Dhar P, Jhaveri K, Haider M, Guindi M, Heathcote EJ. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging. Hepatology. 2008;47:949–57.

    Article  CAS  PubMed  Google Scholar 

  85. Gheorghe L, Iacob S, Gheorghe C, Iacob R, Simionov I, Vadan R, et al. Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease. Eur J Gastroenterol Hepatol. 2004;16:585–92.

    Article  PubMed  Google Scholar 

  86. Czaja AJ, Carpenter HA. Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci. 1996;41:305–14.

    Article  CAS  PubMed  Google Scholar 

  87. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology. 1993;18:10–5.

    Article  CAS  PubMed  Google Scholar 

  88. Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut. 1994;35:260–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Taylor SL, Dean PJ, Riely CA. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol. 1994;18:91–9.

    Article  CAS  PubMed  Google Scholar 

  90. Sherlock S. Ludwig Symposium on biliary disorders. Autoimmune cholangitis: a unique entity? Mayo Clin Proc. 1998;73:184–90.

    Article  CAS  PubMed  Google Scholar 

  91. Romero-Gomez M, Wichmann I, Crespo J, Pares A, Rodrigo L, Alvarez A, et al. Serum immunological profile in patients with chronic autoimmune cholestasis. Am J Gastroenterol. 2004;99:2150–7.

    Article  CAS  PubMed  Google Scholar 

  92. Wee A, Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? Ann Intern Med. 1985;102:581–7.

    Article  CAS  PubMed  Google Scholar 

  93. Bizzaro N, Covini G, Rosina F, Muratori P, Tonutti E, Villalta D, et al. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. Clin Rev Allergy Immunol. 2010. doi:10.1007/s12016-010-8234-y.

  94. Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, Bizzaro N, et al. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun. 2010;35:436–42.

    Article  CAS  PubMed  Google Scholar 

  95. Umemura T, Zen Y, Hamano H, Ichijo T, Kawa S, Nakanuma Y, et al. IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis. Gut. 2007;56:1471–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Chung H, Watanabe T, Kudo M, Maenishi O, Wakatsuki Y, Chiba T. Identification and characterization of IgG4-associated autoimmune hepatitis. Liver Int Off J Int Assoc Study Liver. 2010;30:222–31.

    Article  CAS  Google Scholar 

  97. Umemura T, Zen Y, Hamano H, Joshita S, Ichijo T, Yoshizawa K, et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol. 2011;46 Suppl 1:48–55.

    Article  CAS  PubMed  Google Scholar 

  98. Deshpande V, Sainani NI, Chung RT, Pratt DS, Mentha G, Rubbia-Brandt L, et al. IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material. Mod Pathol. 2009;22:1287–95.

    Article  CAS  PubMed  Google Scholar 

  99. Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–15.

    Article  PubMed  Google Scholar 

  100. Bjornsson E, Chari S, Silveira M, Gossard A, Takahashi N, Smyrk T, et al. Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy. Am J Ther. 2011;18:198–205.

    Article  PubMed  Google Scholar 

  101. Bjornsson E, Chari ST, Smyrk TC, Lindor K. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology. 2007;45:1547–54.

    Article  PubMed  Google Scholar 

  102. Montano-Loza AJ, Lalor E, Mason AL. Recognizing immunoglobulin G4 related overlap syndromes in patients with pancreatic and hepatobiliary diseases. Can J Gastroenterol. 2008;22:840–6.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Czaja AJ. Extrahepatic immunologic features of chronic viral hepatitis. Dig Dis. 1997;15:125–44.

    Article  CAS  PubMed  Google Scholar 

  104. Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci. 2011;56:958–76.

    Article  CAS  PubMed  Google Scholar 

  105. Loria P, Lonardo A, Leonardi F, Fontana C, Carulli L, Verrone AM, et al. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci. 2003;48:2173–81.

    Article  PubMed  Google Scholar 

  106. Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2004;99:1316–20.

    Article  CAS  PubMed  Google Scholar 

  107. Czaja AJ, Santrach PJ, Breanndan Moore S. Shared genetic risk factors in autoimmune liver disease. Dig Dis Sci. 2001;46:140–7.

    Article  CAS  PubMed  Google Scholar 

  108. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology. 1991;13:701–6.

    Article  CAS  PubMed  Google Scholar 

  109. Strettell MD, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology. 1997;112:2028–35.

    Article  CAS  PubMed  Google Scholar 

  110. Czaja AJ, Strettell MD, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology. 1997;25:317–23.

    Article  CAS  PubMed  Google Scholar 

  111. Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology. 1994;19:609–15.

    Article  CAS  PubMed  Google Scholar 

  112. Boberg KM, Lundin KE, Schrumpf E. Etiology and pathogenesis in primary sclerosing cholangitis. Scand J Gastroenterol Suppl. 1994;204:47–58.

    Article  CAS  PubMed  Google Scholar 

  113. Donaldson PT, Norris S. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity. 2002;35:555–64.

    Article  CAS  PubMed  Google Scholar 

  114. Agarwal K, Czaja AJ, Jones DE, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology. 2000;31:49–53.

    Article  CAS  PubMed  Google Scholar 

  115. Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol. 2000;32:538–41.

    Article  CAS  PubMed  Google Scholar 

  116. Juran BD, Atkinson EJ, Schlicht EM, Fridley BL, Petersen GM, Lazaridis KN. Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. Hepatology. 2008;47:563–70.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Joshita S, Umemura T, Yoshizawa K, Katsuyama Y, Tanaka E, Nakamura M, et al. Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients. J Hepatol. 2010;53:537–41.

    Article  CAS  PubMed  Google Scholar 

  118. Czaja AJ. Autoimmune hepatitis. Part A: pathogenesis. Expert Rev Gastroenterol Hepatol. 2007;1:113–28.

    Article  CAS  PubMed  Google Scholar 

  119. Czaja AJ. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin Gastroenterol Hepatol. 2008;6:379–88.

    Article  CAS  PubMed  Google Scholar 

  120. Czaja AJ. Transitioning from idiopathic to explainable autoimmune hepatitis. Dig Dis Sci. 2015. doi:10.1007/s10620-015-3708-7.

  121. Mieli-Vergani G, Lobo-Yeo A, McFarlane BM, McFarlane IG, Mowat AP, Vergani D. Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology. 1989;9:198–203.

    Article  CAS  PubMed  Google Scholar 

  122. Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. Arch Dis Child. 1992;67:1447–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Gleeson D, Heneghan MA. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011;60:1611–29.

    Article  CAS  PubMed  Google Scholar 

  124. Beuers U, Boberg KM, Chapman RW, Chazouilleres O, Invernizzi P, Jones DEJ, et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237–67.

    Article  CAS  Google Scholar 

  125. Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology. 1997;25:541–7.

    Article  CAS  PubMed  Google Scholar 

  126. Lawrence SP, Sherman KE, Lawson JM, Goodman ZD. A 39 year old man with chronic hepatitis. Semin Liver Dis. 1994;14:97–105.

    Article  CAS  PubMed  Google Scholar 

  127. Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology. 2009;50:808–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Sinakos E, Marschall HU, Kowdley KV, Befeler A, Keach J, Lindor K. Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression. Hepatology. 2010;52:197–203.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street S.W., Rochester, MN, USA

    Albert J. Czaja MD

Authors
  1. Albert J. Czaja MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Albert J. Czaja MD .

Editor information

Editors and Affiliations

  1. Department of Gastroenterology-Hepatology, University of Colorado, Aurora, Colorado, USA

    Lisa M. Forman

Additional information

This review did not receive financial support from a funding agency or institution, and Albert J. Czaja, MD has no conflict of interests to declare.

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Czaja, A.J. (2017). Overlap Syndromes of Primary Sclerosing Cholangitis. In: Forman, L. (eds) Primary Sclerosing Cholangitis. Springer, Cham. https://doi.org/10.1007/978-3-319-40908-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-40908-5_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-40906-1

  • Online ISBN: 978-3-319-40908-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation